Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis-Reference-Cited by-同舟云学术

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

Published:1997-08 Issue:9074 Volume:350 Page:309-318
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Boers Maarten,Verhoeven Arco C,Markusse Harry M,van de Laar Mart AFJ,Westhovens Rene,van Denderen J Christiaan,van Zeben Derkjen,Dijkmans Ben AC,Peeters Andre J,Jacobs Piet,van den Brink Hans R,Schouten Hubert JA,van der Heijde Désirée MFM,Boonen Annelies,van der Linden Sjef

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Management of rheumatoid arthritis;Harris,1993

2. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis;van der Heijde;Lancet,1989

3. Antirheumatic drugs: a proposed new classification;Edmonds;Arthritis Rheum,1993

4. The effectiveness of early treatment with ‘second-line’ antirheumatic drugs, a randomised, controlled trial;Van der Heide;Ann Intern Med,1996

5. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-dose Glucocorticoid Study Group;Kirwan;N Engl J Med,1995

Cited by 886 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retention of triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine compared to combination methotrexate and leflunomide in rheumatoid arthritis;Joint Bone Spine;2024-07

2. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07

3. Clinical practice guidelines for the early detection, diagnosis, treatment, and follow-up of patients with rheumatoid arthritis. Colombian Association of Rheumatology, 2022;Revista Colombiana de Reumatología (English Edition);2024-04

4. Current Prospects in Rheumatoid Arthritis: Pathophysiology, Genetics, and Treatments;Recent Advances in Anti-Infective Drug Discovery;2024-04

5. Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis;Seminars in Arthritis and Rheumatism;2024-02